Ponesimod
| CAS号 | 854107-55-4 | 货号 | BCP17902 |
| 中文名 | Ponesimod | ||
| 英文名 | Ponesimod | ||
| 中文别名 | |||
| 英文别名 | ACT-128800; | ||
| 分子式 | C23H25ClN2O4S | 分子量 | 460.97 |
| 生物活性 | Ponesimod, also known as ACT-128800, is a potent, and orally active selective S1P(1) agonist. Ponesimod activated S1P(1)-mediated signal transduction with high potency (EC(50) of 5.7 nM) and selectivity. Ponesimod prevented edema formation, inflammatory cell accumulation, and cytokine release in the skin of mice with delayed-type hypersensitivity. Ponesimod also prevented the increase in paw volume and joint inflammation in rats with adjuvant-induced arthritis. Ponesimod may represent a new therapeutic approach in lymphocyte-mediated autoimmune diseases. | ||
| 信号通路 | GPCR/G Protein | ||
| 靶 点 | S1P Receptor | ||
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！